SEC Form 4 · accession 0000899243-16-024068
Larimar Therapeutics, Inc. · LRMR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cameron Geoffrey McDonough
Director
Period of report
Jun 30, 2016
Accepted (ET)
Jul 1, 2016 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374690
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $5.99 | Jun 30, 2016 | A | 12,000 | A | — | Jun 30, 2026 | Common Stock | 12,000 | 12,000 | D |
Explanation of responses
- F1These options were issued under the nonemployee director compensation policy and will vest in full upon the earlier of June 30, 2017 or the date of the 2017 annual meeting of stockholders, subject to the director's continued service on the board of directors.